coin-img-ETHETH+0.66%coin-img-BTCBTC+0.18%coin-img-SOLSOL+0.72%coin-img-XRPXRP+4.01%coin-img-USDCUSDC+0.00%coin-img-HYPEHYPE+6.51%coin-img-TRXTRX-2.02%coin-img-TONCOINTONCOIN-0.62%coin-img-ETHETH+0.66%coin-img-BTCBTC+0.18%coin-img-SOLSOL+0.72%coin-img-XRPXRP+4.01%coin-img-USDCUSDC+0.00%coin-img-HYPEHYPE+6.51%coin-img-TRXTRX-2.02%coin-img-TONCOINTONCOIN-0.62%coin-img-ETHETH+0.66%coin-img-BTCBTC+0.18%coin-img-SOLSOL+0.72%coin-img-XRPXRP+4.01%coin-img-USDCUSDC+0.00%coin-img-HYPEHYPE+6.51%coin-img-TRXTRX-2.02%coin-img-TONCOINTONCOIN-0.62%coin-img-ETHETH+0.66%coin-img-BTCBTC+0.18%coin-img-SOLSOL+0.72%coin-img-XRPXRP+4.01%coin-img-USDCUSDC+0.00%coin-img-HYPEHYPE+6.51%coin-img-TRXTRX-2.02%coin-img-TONCOINTONCOIN-0.62%
user-avatar
CNBC

Eli Lilly to buy three private vaccine developers in deals worth nearly $4 billion

Eli Lilly said Tuesday it plans to acquire three privately held vaccine companies in transactions valued at nearly $4 billion in total. The deals include up to $1.5 billion for Curevo, up to $780 million for LimmaTech Biologics, and up to $1.55 billion for Vaccine Company, with programs targeting shingles, staph infections and Epstein-Barr virus.
Avis de non-responsabilité : le contenu ci-dessus n'engage que l'auteur et ne constitue en aucun cas l'opinion de BingX. Ce contenu ne doit pas être interprété comme un conseil en investissement de la part de BingX. Pour plus de détails, veuillez vous référer aux Conditions générales.